This inventor holds 2 USPTO granted patents. Top assignees: Elan Pharmaceuticals, Inc., Integra Lifesciences Corporation. Active years: 2001-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2007
Title: Dawn McGuire: Innovator in Medical Treatments
Introduction
Dawn McGuire is a notable inventor based in Berkeley, CA, who has made significant contributions to the field of medical treatments. With a total of 2 patents, her work focuses on innovative methods for addressing critical health issues.
Latest Patents
Among her latest patents is a method for the treatment of normal pressure hydrocephalus. This method involves removing cerebral spinal fluid (CSF) from a CSF space of a patient while maintaining pressure within an expected normal range. Another significant patent is for the transdermal administration of fenoldopam. This patent describes both the racemic mixture and the active R-fenoldopam enantiomer, along with transdermal patches designed for effective treatment of impaired renal function or hypertension.
Career Highlights
Dawn has worked with prominent companies such as Integra Lifesciences Corporation and Elan Pharmaceuticals, Inc. Her experience in these organizations has contributed to her expertise in developing innovative medical solutions.
Collaborations
Dawn has collaborated with several professionals in her field, including Gerald Silverberg and Vandana Mathur. These collaborations have further enhanced her research and development efforts.
Conclusion
Dawn McGuire's contributions to medical innovation through her patents and collaborations highlight her role as a significant inventor in the healthcare industry. Her work continues to impact the treatment of various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile